The data presented here as well as those from others (9, 10, 27) suggest that in individuals with obesity, resveratrol treatment can be sufficient in ameliorating insulin resistance independent of improvement in insulin signal transduction. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.